View Profile

Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. 51st ASH Annual Meeting, New Orleans, LA December, 2009
2. Society for Hematopathology Workshop, Cleveland, OH September, 2009
3. Upcoming Trends in the Treatment of Hematological Malignancies, First Annual Oncology Conference, Hackensack University Medical Center, Hackensack, NJ September, 2009
4. 2009 Onoology Highlights, News from the 45th ASCO Annual Meeting, Santa Monica, CA August, 2009
5. International Socity for Laboratory Hematology, XXIInd Interntional Symposium on Technological Innovations in Laboratory Hemtology, Las Vegas, NV May, 2009
6. American Society of Clinical Oncology, Orlando, FL May, 2009
7. Great Debates and Updates in Hematology, Boca Raton, FL April, 2009
8. International Myeloma Workshop, Washington, DC February, 2009
9. Weill Cornell Medical College, Center of Excellence for Myeloma and Lymphoma, The Richard Lent Memorial Multiple Myeloma Lecture Series, New York, NY December, 2008
10. Erming Tian PhD Thesis Defense, Trondheim, Norway November, 2008
11. Annual Meeting of Society of Utah Medical Oncologists, Park City, UT October, 2008
12. Mayo Alumni Meeting, Puebla, Mexico September, 2008
13. 10th International Conference on Malignant Lymphoma, Lugano, Switzerland June, 2008
14. Nevada Cancer Center, Las Vegas, NV June, 2008
15. Oncology Nursing Society Congress CME May, 2008
16. American Society of Clinical Oncology, Chicago, IL May, 2008
17. University of Southern California, Los Angeles, CA Grand Rounds May, 2008
18. Hematology Highlights from the American School of Oncology 49th Annual Hematology Meeting February, 2008
19. International Hematology Symposium, San Jose February, 2008
20. Best of ASH, Seattle February, 2008
21. Mayo Clinic State of the Art Symposium – Hematologic Malignancies January, 2008
22. American Society of Hematology Annual Meeting December, 2007
23. Kettering Health Network Tumor Board, Kettering November, 2007
24. Multiple Myeloma Research Foundation Institutional Insights, Stanford University November, 2007
25. Washington University, Malignant Hematology Conference October, 2007
26. Memorial Sloan-Kettering Cancer Center, Grand Rounds October, 2007
27. The American School of Hematology, Great Debates in Hematology September, 2007
28. International Myeloma Foundation Symposium September, 2007
29. XI International Myeloma Workshop June, 2007
30. MMRF Scientific Agenda Roundtable March, 2007
31. Immunomodulation: Assessing the Science in Hematologic Malignancies American Society of Hematology Annual Meeting December, 2006
32. Multiple Myeloma Update. New Development in Hematological Malignancies, Detroit, MI October, 2006
33. The Biology of Myeloma: Cytogenetics, FISH and Beyond Lymphoma and Myeloma Conference October, 2006
34. Top Therapeutic Targets For Multiple Myeloma. Multiple Myeloma Research Consortium October, 2006
35. The place of bone marrow transplantation in the Bortezomib Era. Brazilian Bone Marrow Transplantation Congress Satellite Symposium, Curitiba, Brazil. August, 2006
36. Cytogenetics and molecular cytogenetics in myeloma: the path to discovery and the need in the clinic NCI chromosome workshop -50 years of 46 chromosomes: Progress in Cytogenetics July, 2006
37. Myeloma Genetics, Clinical and Prognostic Implication. 2nd Genetics Pathogenesis Roundtable June, 2006
38. The Role of Molecular Diagnostics for Patient Management in Multiple Myeloma and Leukemia 11th Congress of the European Hematology Association June, 2006
39. Highlights of the Day – Multiple Myeloma 2006 ASCO Annual Meeting, Atlanta, GA. June, 2006
40. Symposium – Integration of Novel Therapies into Current Treatment of Myeloma: An Evolving Paradigm. Diagnosis, Prognosis and Staging 2006 ASCO Annual Meeting, Atlanta, GA. June, 2006
41. Application of Cytogenetics in Treatment of Multiple Myeloma Symposium: The Promise of Proteasome Inhibition: Future Directions in Multiple Myeloma and Non-Hodgkin’s Lymphoma, April, 2006
42. New Concepts in Organ-Site Research Session. Genomics of Myeloma American Association for Cancer Research 97th Annual Meeting April, 2006
43. University of Arizona College of Medicine, Tucson, AZ, Grand Rounds February, 2006
44. Myeloma Genetics, Clinical and Prognostic Implication Blood SPORE Winter Conference, City of Hope, Duarte, CA February, 2006
45. Diagnosis, Classification, Prognosis, Staging 3rd Mayo Clinic State of the Art Symposium on Hematologic Malignancies, Scottsdale, AZ. January, 2006
46. Myeloma Genetics, Clinical & Prognostic Implication i3dln Educational Conference, LAC/USC Medical Center, Los Angeles, CA December, 2005
47. Cytogenetics, Molecular Genetics, and Prognostic Factors in Myeloma Millennium Pharmaceuticals: The Promise of Proteasome Inhibition: Future Directions in Multiple Myeloma and Lymphoma, Atlanta, GA December, 2005
48. Newer Approaches in the Treatment of Multiple Myeloma: Do Emerging Therapies Offer and Advantage? Chandler Regional Hospital Grand Rounds, Chandler December, 2005
49. Multiple Myeloma St. Vincent Hospital Grand Rounds, Santa Fe, NM November, 2005
50. Myeloma Genetics, Clinical and Prognostic Implication Comprehensive Cancer Center, Palm Springs November, 2005
51. Myeloma Genetics Kyoto Prefectural University of Medicine November, 2005
52. Cytogenetic Abnormalities in MM. Japanese Society of Multiple Myeloma November, 2005
53. Relapse Treatment and Novel Therapies. IMF Patient and Family Seminar August, 2005
54. Genetics of Myeloma and Amyloidosis 15th Annual Hematology Oncology Reviews July, 2005
55. FISH en el diagnostico de Mieloma 22nd Congress of the Spanish Society of Anatomic Pathology, Palma de Mallorca May, 2005
56. (1) Is Myeloma Becoming a Chronic Disease? Evaluating Results of Revlimdâ„¢ Studies. (2) Chromosome 13 and bortezomid: Clinical Implications. ASCO Annual Meeting May, 2005
57. WaldenstrÖm macroglobulinemia; genetics and cytogenetics IWMF Support Group May, 2005
58. Genetics and Genomics of Myeloma USC Keck School of Medicine, Hematology Grand Rounds April, 2005
59. Genomics: Unlocking the Mysteries of Myeloma Multiple Myeloma Satellite Symposium April, 2005
60. Integration of Genetics in a Comprehensive Pathogenesis Model for Myeloma 10th International Myeloma Workshop April, 2005
61. What is new in MM? Leukemia & Lymphoma Society, Phoenix, AZ March, 2005
62. Amyloidosis” and “Genomic Tools for the 21st Century Jornadas Medicas del Hospital Español. Mexico City, Mexico February, 2005
63. What is new in MM? IWMF Support Group, Phoenix, AZ February, 2005
64. University of New Mexico. Medical Grand Rounds, Myeloma Biology, Clinical Implications of Genomics February, 2005
65. American Association for Cancer Research Special Conference, San Diego, CA February, 2005
66. MMRF Scientific Advisors Summit January, 2005

Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Debate: For newly diagnosed multiple myeloma patients who relapse from a ≥VGPR response more than 12 months following frontline therapy, what is the best salvage strategy? Great Debates and Updates in Hematologic Malignancies May, 2010
How I manage multiple myeloma patients who present with significant pre-existing illnesses or serious complications of the myeloma: Great Debates and Updates in Hematologic Malignancies May, 2010
Keynote Presentation: Integrated Therapies: A View From the Bench Sixth Annual Symposium on Controversies and Clinical Challenges In Lymphoma, Myeloma, and Leukemia September, 2009

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.